Novartis in Advanced Talks to Buy Cytokinetics
Wall Street Journal
Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug.
https://www.wsj.com/articles/novartis-in-advanced-talks-to-buy-cytokinetics-d1032569
Understanding current events through the lenses of the past and future.
Wall Street Journal
Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug.
https://www.wsj.com/articles/novartis-in-advanced-talks-to-buy-cytokinetics-d1032569